Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Ropivacaine Hydrochloride injection
Status: Currently in Shortage
»Date first posted:
03/23/2018
»Therapeutic Categories: Anesthesia
Caplin Steriles, Ltd. (Revised 04/12/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2 mg/1 mL (NDC 43066-015-10) | Unavailable | Limited supply; Recovery: April 2024; Check wholesalers for inventory; Marketed by Baxter | Demand increase for the drug |
| Injection, 5 mg/1 mL (NDC 43066-019-10) | Available | Check wholesalers for inventory; Marketed by Baxter | |
| Injection, 5 mg/1 mL (NDC 43066-023-10) | Unavailable | Limited supply; Recovery: April 2024; Check wholesalers for inventory; Marketed by Baxter | Demand increase for the drug |
| Injection, 10 mg/1 mL (NDC 43066-027-10) | Available | Check wholesalers for inventory; Marketed by Baxter |
Eugia US LLC (Revised 03/22/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2 mg/1 mL (NDC 55150-195-20) | Available | Sporadic availability expected. | |
| Injection, 2 mg/1 mL (NDC 55150-196-99) | Available | Check wholesalers for inventory | |
| Injection, 5 mg/1 mL (NDC 55150-197-20) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Injection, 5 mg/1 mL (NDC 55150-198-30) | Available | Intermittent availability expected | Demand increase for the drug |
| Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Available | Check wholesalers for inventory | |
| Injection, 10 mg/1 mL (NDC 55150-200-10) | Available | Check wholesalers for inventory | |
| Injection, 10 mg/1 mL (NDC 55150-201-20) | Available | Intermittent availability expected | Demand increase for the drug |
Fresenius Kabi USA, LLC (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Unavailable | Next release not available at this time. | Demand increase for the drug |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Available | ||
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Available | ||
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Available | Available. Check wholesaler for inventory. | |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Available | ||
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Available | ||
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Available | ||
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Available | ||
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Available | ||
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Available | ||
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Available | ||
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Available | ||
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Available | ||
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Unavailable | Next release not available at this time. | Delay in shipping of the drug |
InfoRLife SA (Reverified 03/06/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | Available | Marketed by Sagent Pharmaceuticals | |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | Available | Marketed by Sagent Pharmaceuticals | |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | Available | Marketed by Sagent Pharmaceuticals | |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | Available | Marketed by Sagent Pharmaceuticals | |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | Available | Marketed by Sagent Pharmaceuticals | |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | Available | Marketed by Sagent Pharmaceuticals |
Somerset Therapeutics, LLC (Revised 04/01/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2 mg/1 mL (NDC 70069-061-10) | Available | ||
| Injection, 2 mg/1 mL (NDC 70069-061-25) | Available | ||
| Injection, 2 mg/1 mL (NDC 70069-062-10) | Available | ||
| Injection, 2 mg/1 mL (NDC 70069-062-25) | Available | ||
| Injection, 5 mg/1 mL (NDC 70069-064-01) | Available | ||
| Injection, 5 mg/1 mL (NDC 70069-064-10) | Available | ||
| Injection, 5 mg/1 mL (NDC 70069-064-25) | Available |